The new 200,000 sq ft facility in Blaine, Washington State will make both generic pharmaceuticals and over-the-counter (OTC) medications, including hard and soft shell capsules, as well as nutritional and dietary supplements and cosmetics.

The firm also plans to carry out R&D at the site, including the development of new pharmaceutical products and associated technologies.

Viva already has distribution subsidiaries and sales agents in Asia and the Middle East, however its recent focus has been on growing its North American business and the world's biggist drugmarket in particular.